I think they will release some revenue guidance soon. You don't just go looking to list as a minnow pharma if you have nothing to sell yourself with. This is a sign of confidence in the company IMO. Bigger things to unfold and management are looking to roll out their plans nicely.
secondary listing on nasdaq, page-10
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
